SVB Leerink analyst Daina Graybosch maintains BioNTech (NASDAQ:BNTX) with a Market Perform and raises the price target from $110 to $118.
‘$EYES Second Sight Medical has been granted European patent number EP2839858 titled “Field focusing and mapping in an electrode array”.’ – PatentGrants
https://twitter.com/PatentGrants/status/1417930776406937600